Elsevier is doing its own investigation into whether an "Editor's Choice" article appearing in the May 2003 issue of the American Journal of Obstetrics and Gynecology was "improperly ghostwritten by a drug company promoting the product," the New York Times reports.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.